Literature DB >> 28878299

A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia.

Xiaobo Fang1, Yanling Liang1, Dunjin Chen2, Fang He2, Jia Chen1, Fami Huang1.   

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is a critical maternal complication in preeclampsia or eclampsia during pregnancy. However, studies regarding the clinicoradiological and outcome differences between RPLS and non-RPLS pregnancies are scarce. We aimed to explore the incidence of RPLS, and summarize the clinicoradiological characteristics and pregnancy outcomes. We consecutively collected a total of 100 patients who were diagnosed with preeclampsia or eclampsia, and examined via magnetic resonance imaging (MRI) among 21 872 women between 2013 and 2016. All patients were grouped into RPLS (n=49) and non-RPLS (n=51) groups according to their MRI results. Information about clinicoradiological features and pregnancy outcomes was collected retrospectively to explore the differences between the groups. The incidence of RPLS in pregnant women was 0.22% (49/21 872). The frequency of clinical symptoms, such as headache, vision change, seizure and consciousness disorders, and blood pressure conditions, such as severely elevated hypertension, systolic and diastolic pressure and mean arterial pressure levels, was increased in the RPLS group compared with that in the non-RPLS group (P<0.05). The occipital lobe was the most frequently affected area (93.88%) in RPLS patients. The cesarean section rate in RPLS group was higher than the non-RPLS group (P<0.05), whereas the 1 min Apgar score was lower (P<0.05). These results suggest that the incidence of RPLS was high. Information about clinical symptoms and blood pressure was useful in predicting RPLS. In addition, RPLS was significantly associated with the delivery mode and pregnancy outcomes. The most frequently affected area was the occipital lobe.

Entities:  

Mesh:

Year:  2017        PMID: 28878299     DOI: 10.1038/hr.2017.76

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  24 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

Authors:  Guido Granata; Antonio Greco; Giannicola Iannella; Massimo Granata; Alessandra Manno; Ersilia Savastano; Giuseppe Magliulo
Journal:  Autoimmun Rev       Date:  2015-05-18       Impact factor: 9.754

3.  Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

Authors:  A Marra; M Vargas; P Striano; L Del Guercio; P Buonanno; G Servillo
Journal:  Med Hypotheses       Date:  2014-03-01       Impact factor: 1.538

4.  Clinical and perinatal outcomes in eclamptic women with posterior reversible encephalopathy syndrome.

Authors:  Zehra Kurdoglu; Orkun Cetin; Refah Sayın; Deniz Dirik; Mertihan Kurdoglu; Ali Kolusarı; Recep Yıldızhan; H Guler Sahin
Journal:  Arch Gynecol Obstet       Date:  2015-05-01       Impact factor: 2.344

Review 5.  The posterior reversible encephalopathy syndrome: what's certain, what's new?

Authors:  C Roth; A Ferbert
Journal:  Pract Neurol       Date:  2011-06

Review 6.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

7.  Health of children born to mothers who had preeclampsia: a population-based cohort study.

Authors:  Chun S Wu; Ellen A Nohr; Bodil H Bech; Mogens Vestergaard; Janet M Catov; Jørn Olsen
Journal:  Am J Obstet Gynecol       Date:  2009-09       Impact factor: 8.661

Review 8.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David J Williams
Journal:  BMJ       Date:  2007-11-01

9.  Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.

Authors:  E Abalos; C Cuesta; G Carroli; Z Qureshi; M Widmer; J P Vogel; J P Souza
Journal:  BJOG       Date:  2014-03       Impact factor: 6.531

10.  Posterior reversible encephalopathy syndrome: differences between pregnant and non-pregnant patients.

Authors:  Luiz Carlos Porcello Marrone; Giovani Gadonski; Luciano Passamani Diogo; João Pedro Farina Brunelli; William Alves Martins; Gabriela de Oliveira Laguna; Laura Fuchs Bahlis; João Rubião Hoefel Filho; Bartira Ercilia Pinheiro da Costa; Carlos Eduardo Poli-de-Figueiredo; Antônio Carlos Huf Marrone; Jaderson Costa da Costa
Journal:  Neurol Int       Date:  2014-03-24
View more
  2 in total

1.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

2.  Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome.

Authors:  Xiaobo Fang; Yanling Liang; Weixi Zhang; Qiong Wang; Jingsi Chen; Jia Chen; Yongqiang Lin; Yanli Chen; Li Yu; Haibin Wang; Dunjin Chen
Journal:  Mol Neurobiol       Date:  2021-09-22       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.